ALS Education Specialist

I’m Lillian, your ALS Education Specialist.

ALS Education Specialist

I'm still available to chat.

Call

Get answers about starting RADICAVA®
Call 1-855-4-JRNY-M8 (1-855-457-6968)

Close
Get ALS and RADICAVA®
Educational Support
Down arrow icon
Need help?
Talk to someone
who can answer your
important questions

Call toll-free
1-855-457-6968
Learn more

Down arrow icon
Learn how
RADICAVA® may help
Down arrow icon
Talk to your ALS Education Specialist
who specializes in helping you
understand RADICAVA®

Call toll-free
1-855-457-6968
Learn more

Down arrow icon

THE RADICAVA® EDUCATIONAL COMMUNICATION SERIES—SIGN UP TODAY

Join our community of 10,000+ people who've signed up for this educational communication series to learn more about RADICAVA® (edaravone) and why this ALS treatment matters to patients and caregivers. Updates in the series will educate you about:


RADICAVA® (edaravone) shield icon

How RADICAVA® May Help

Get patient-friendly information about the effectiveness and safety of RADICAVA® (edaravone) that's designed to be easy to understand.

RADICAVA® (edaravone) experiences

Real RADICAVA® Experiences

See what RADICAVA® means to patients and caregivers as they share their personal experiences with treatment.

Piggy bank icon

RADICAVA® Cost Support

Learn more about a range of cost support programs for eligible patients.

For eligibility requirements and terms and conditions, click here.

Stack of papers icon

And Much More

You'll also receive additional ALS resources and support information when you sign up for the educational series.

Sign up now with the form below to begin receiving this informative educational series.

Reference: 1. Data on file. Mitsubishi Tanabe Pharma America, Inc.

Important Safety Information

Before you receive Radicava® (edaravone), tell your healthcare provider about all of your medical conditions, including if you:

  • have asthma.
  • are allergic to other medicines.
  • are pregnant or plan to become pregnant. It is not known if Radicava® will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Radicava® passes into your breastmilk. You and your healthcare provider should decide if you will receive Radicava® or breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of Radicava®?

  • Radicava® may cause serious side effects, including hypersensitivity (allergic) reactions and sulfite allergic reactions.
  • Hypersensitivity reactions have happened in people receiving Radicava® and can happen after your infusion is finished.
  • Radicava® contains sodium bisulfite, a sulfite that may cause a type of allergic reaction that can be serious and life-threatening. Sodium bisulfite can also cause less severe asthma episodes in certain people. Sulfite sensitivity can happen more often in people who have asthma than in people who do not have asthma.
  • Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives; swelling of the lips, tongue, or face; fainting; breathing problems; wheezing; trouble swallowing; dizziness; itching; or an asthma attack (in people with asthma).
  • Your healthcare provider will monitor you during treatment to watch for signs and symptoms of all the serious side effects.

The most common side effects of Radicava® include bruising (contusion), problems walking (gait disturbance), and headache.

These are not all the possible side effects of Radicava®. Call your healthcare provider for medical advice about side effects. You may report side effects to Mitsubishi Tanabe Pharma America, Inc. at 1-888-292-0058 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Indication

Radicava® is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Please see full Prescribing Information and Patient Information.

For more information about RADICAVA®, call 1-844-SRCHLGT ( 1-844-772-4548).